CVS HEALTH Corp Proceeds from Stock Issuance 2007-2026 | CVS
Beta
What is CVS HEALTH Corp's current proceeds from stock issuance?
CVS HEALTH Corp (CVS) annual proceeds from stock issuance for 2025 was $394.0M, a 9.14% increase from 2024. CVS HEALTH Corp proceeds from stock issuance for the quarter ending March 31, 2026 was $103.0M.
What was CVS HEALTH Corp's proceeds from stock issuance in 2024?
CVS HEALTH Corp annual proceeds from stock issuance for 2024 was $361.0M, a 30.32% increase from 2023.
What was CVS HEALTH Corp's proceeds from stock issuance in 2023?
CVS HEALTH Corp annual proceeds from stock issuance for 2023 was $277.0M, a 49.73% decline from 2022.
What is CVS HEALTH Corp's 5-year proceeds from stock issuance CAGR?
CVS HEALTH Corp proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 8.34% from FY2020 to FY2025, going from $264.0M to $394.0M over 5 years.
Proceeds from Stock Issuance History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+8.3%
FY2020
$264.0M
→
FY2025
$394.0M
07080910111213141516171819202122232425
5 years selected
Proceeds from Stock Issuance History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $394.0M | +9.1% | 10-K |
| FY2024 | $361.0M | +30.3% | 10-K |
| FY2023 | $277.0M | -49.7% | 10-K |
| FY2022 | $551.0M | +0.4% | 10-K |
| FY2021 | $549.0M | +108.0% | 10-K |
| FY2020 | $264.0M | +25.7% | 10-K |
| FY2019 | $210.0M | -13.2% | 10-K |
| FY2018 | $242.0M | -26.4% | 10-K |
| FY2017 | $329.0M | +11.1% | 10-K |
| FY2016 | $296.0M | -18.2% | 10-K |
| FY2015 | $362.0M | -14.0% | 10-K |
| FY2014 | $421.0M | -15.8% | 10-K |
| FY2013 | $500.0M | -40.2% | 10-K |
| FY2012 | $836.0M | +94.0% | 10-K |
| FY2011 | $431.0M | +51.2% | 10-K |
| FY2010 | $285.0M | +14.0% | 10-K |
| FY2009 | $250.0M | -23.8% | 10-K |
| FY2008 | $328.0M | -40.7% | 10-K |
| FY2007 | $553.0M | - | 10-K |
Company: CVS HEALTH CorpTicker: CVSSector: HealthcareIndustry: Retail-Drug Stores and Proprietary StoresView company profile →